Analysts Set Solventum Co. (NYSE:SOLV) Price Target at $68.00

Solventum Co. (NYSE:SOLV) has been assigned a consensus recommendation of “Hold” from the ten research firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $68.00.

Several equities research analysts recently weighed in on the company. Stifel Nicolaus began coverage on Solventum in a research note on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price target on the stock. Wells Fargo & Company reduced their target price on shares of Solventum from $69.00 to $64.00 and set an “equal weight” rating on the stock in a research report on Friday, August 9th. Piper Sandler lifted their price target on shares of Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. The Goldman Sachs Group upped their price objective on shares of Solventum from $48.00 to $54.00 and gave the stock a “sell” rating in a report on Monday, August 12th. Finally, Wolfe Research initiated coverage on shares of Solventum in a report on Thursday, September 26th. They set a “peer perform” rating for the company.

Institutional Trading of Solventum

Several large investors have recently modified their holdings of the company. Price T Rowe Associates Inc. MD purchased a new position in Solventum in the first quarter worth about $5,889,000. Mitsubishi UFJ Trust & Banking Corp purchased a new stake in Solventum during the first quarter valued at approximately $5,747,000. CWM LLC purchased a new stake in Solventum during the second quarter valued at approximately $473,000. Great Valley Advisor Group Inc. bought a new position in Solventum in the 2nd quarter worth $493,000. Finally, First Horizon Advisors Inc. bought a new position in shares of Solventum in the second quarter worth about $58,000.

Solventum Trading Up 1.7 %

Shares of SOLV stock opened at $70.81 on Thursday. The stock has a fifty day moving average of $70.53 and a 200 day moving average of $62.33. Solventum has a 52 week low of $47.16 and a 52 week high of $96.05. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.